SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Pharma Science informs about ratings

22 Jan 2021 Evaluate

Strides Pharma Science has informed that India Ratings and Research (Ind-Ra) through its letter dated January 21, 2021 has upgraded company’s Long-Term Issuer Rating to ‘IND A+’ with a Stable Outlook from ‘IND A’ previously.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

1109.90 -16.35 (-1.45%)
08-Jul-2026 10:39 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1912.50
Dr. Reddys Labs. 1366.70
Cipla 1456.80
Zydus Lifesciences 1173.10
Lupin 2516.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: